Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VTGN compared with IFRX: revenue, margins and what each company keeps, and the suppliers and customers both name
VTGN
Vistagen Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
IFRX
InflaRx N.V.
Change
Mkt cap
Revenue
Revenue
vs
Compare
VTGN
Vistagen Therapeutics, Inc.
vs
IFRX
InflaRx N.V.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
VTGN
Vistagen Therapeutics, Inc.
Change
0.17
▲
+0.18%
Mkt cap
$7.5M
Revenue
$1M
Q1 FY27
Revenue
$1M
FY26
IFRX
InflaRx N.V.
Change
1.70
▲
+2.39%
Regular session
Nov 2 '26
Mkt cap
$120.0M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
VTGN
Vistagen Therapeutics, Inc.
vs
IFRX
InflaRx N.V.
0.17
▲
+0.18%
Price
1.70
▲
+2.39%
$7.5M
Mkt cap
$120.0M
Q1 FY27
$1M
Revenue
—
FY26
$1M
Revenue
—
Change
Change
VTGN
0.17
▲
+0.18%
vs
IFRX
1.70
▲
+2.39%
Regular session
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VTGN: latest quarter is a loss; flow not drawable. IFRX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VTGN
4
—
Pherin Pharmaceuticals, Inc. (Pherin)
unlisted
supplier
—
AffaMed
unlisted
customer
—
AffaMed Therapeutics
unlisted
customer
—
Fuji Pharma
unlisted
customer
Shared
0
No disclosed counterparties: IFRX.
Only IFRX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VTGN, solid
IFRX, dashed